citalopram has been researched along with HIV Coinfection in 13 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To test the hypothesis that the selective serotonin reuptake inhibitor (SSRI) citalopram would down-regulate human immunodeficiency virus (HIV) infectivity and that the greatest effects would be seen in people with depression." | 3.76 | Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication. ( Benton, T; Blume, J; Douglas, SD; Dubé, B; Evans, DL; Gettes, DR; Lynch, K; Metzger, DS; Ping Lai, J; Tustin, NB, 2010) |
| "The aims of this study were to characterize escitalopram pharmacokinetic profile, to identify factors influencing drug exposure, notably drug-drug interactions with antiretrovirals, and to simulate expected exposure under standard dosage regimen." | 1.51 | Escitalopram population pharmacokinetics in people living with human immunodeficiency virus and in the psychiatric population: Drug-drug interactions and probability of target attainment. ( Alves Saldanha, S; Buclin, T; Cavassini, M; Courlet, P; Csajka, C; Decosterd, LA; Eap, CB; Glatard, A; Guidi, M; Marzolini, C, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Courlet, P | 1 |
| Guidi, M | 1 |
| Glatard, A | 1 |
| Alves Saldanha, S | 1 |
| Cavassini, M | 1 |
| Buclin, T | 1 |
| Marzolini, C | 1 |
| Eap, CB | 1 |
| Decosterd, LA | 1 |
| Csajka, C | 1 |
| Kolli, V | 1 |
| Addula, M | 1 |
| Hoare, J | 1 |
| Carey, P | 1 |
| Joska, JA | 1 |
| Carrara, H | 1 |
| Sorsdahl, K | 1 |
| Stein, DJ | 1 |
| Greeson, JM | 1 |
| Gettes, DR | 2 |
| Spitsin, S | 1 |
| Dubé, B | 2 |
| Benton, TD | 1 |
| Lynch, KG | 1 |
| Douglas, SD | 2 |
| Evans, DL | 2 |
| Montes, ML | 1 |
| Fraile, JM | 1 |
| González, JJ | 1 |
| Arribas, JR | 1 |
| Mischo, M | 1 |
| Nigg, C | 1 |
| Kiss, A | 1 |
| Benton, T | 1 |
| Lynch, K | 1 |
| Tustin, NB | 1 |
| Ping Lai, J | 1 |
| Metzger, DS | 1 |
| Blume, J | 1 |
| I Lorenzini, K | 1 |
| Calmy, A | 1 |
| Ambrosioni, J | 1 |
| Assouline, B | 1 |
| Daali, Y | 1 |
| Fathi, M | 1 |
| Rebsamen, M | 1 |
| Desmeules, J | 1 |
| Samer, CF | 1 |
| Laguno, M | 1 |
| Blanch, J | 1 |
| Murillas, J | 1 |
| Blanco, JL | 1 |
| León, A | 1 |
| Lonca, M | 1 |
| Larrousse, M | 1 |
| Biglia, A | 1 |
| Martinez, E | 1 |
| García, F | 1 |
| Miró, JM | 1 |
| de Pablo, J | 1 |
| Gatell, JM | 1 |
| Mallolas, J | 1 |
| Ances, BM | 1 |
| Letendre, SL | 1 |
| Alexander, T | 1 |
| Ellis, RJ | 1 |
| Klein, MB | 1 |
| Cooper, C | 1 |
| Brouillette, MJ | 1 |
| Sheehan, NL | 1 |
| Benkelfat, C | 1 |
| Annable, L | 1 |
| Weston, F | 1 |
| Kraus, D | 1 |
| Singer, J | 1 |
| Tietz, A | 1 |
2 reviews available for citalopram and HIV Coinfection
| Article | Year |
|---|---|
[Depression].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; C | 2010 |
Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders.
Topics: Antiretroviral Therapy, Highly Active; Brain; Citalopram; Cognition Disorders; HIV Infections; Human | 2008 |
2 trials available for citalopram and HIV Coinfection
| Article | Year |
|---|---|
Escitalopram treatment of depression in human immunodeficiency virus/acquired immunodeficiency syndrome: a randomized, double-blind, placebo-controlled study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Citalopram; Depressive Disorder, Major; Double-Blind Meth | 2014 |
CTN-194 (PICCO): design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy.
Topics: Antidepressive Agents, Second-Generation; Antiviral Agents; Canada; Citalopram; Depression; Double-B | 2008 |
9 other studies available for citalopram and HIV Coinfection
| Article | Year |
|---|---|
Escitalopram population pharmacokinetics in people living with human immunodeficiency virus and in the psychiatric population: Drug-drug interactions and probability of target attainment.
Topics: Adult; Anti-HIV Agents; Antidepressive Agents, Second-Generation; Biological Variation, Population; | 2019 |
Ondansetron-Induced Myoclonus With Escitalopram and HAART: Role of Drug Interactions.
Topics: Adult; Anti-Anxiety Agents; Antiretroviral Therapy, Highly Active; Anxiety Disorders; Citalopram; Dr | 2019 |
The Selective Serotonin Reuptake Inhibitor Citalopram Decreases Human Immunodeficiency Virus Receptor and Coreceptor Expression in Immune Cells.
Topics: Adolescent; Adult; CD4 Antigens; Citalopram; Depressive Disorder; Down-Regulation; Female; HIV Infec | 2016 |
[Chorea during treatment with pegylated interferon and ribavirin in HIV-HCV coinfected patient].
Topics: Adult; Anti-HIV Agents; Antidepressive Agents; Antiviral Agents; Anxiety Disorders; Chorea; Citalopr | 2009 |
Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD8-Positive T-Lymphocytes; Cell Line; Cells, Cultured; C | 2010 |
Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patient.
Topics: Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Citalopram; Coinfection; Cy | 2012 |
Sexual addiction being studied.
Topics: Behavior, Addictive; Citalopram; HIV Infections; Homosexuality, Male; Humans; Interviews as Topic; M | 2003 |
Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depression; Drug Therapy, Combination; | 2004 |
[Stage CDC C3 HIV infection; V.a. acute serotoninergic syndrome].
Topics: Adult; AIDS-Related Opportunistic Infections; Citalopram; Diagnosis, Differential; Drug Therapy, Com | 1997 |